Page last updated: 2024-08-23

piperacillin and Deafness, Transitory

piperacillin has been researched along with Deafness, Transitory in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Britten, J; Caplan, E; deJongh, CA; Finley, RS; Fortner, CL; Newman, KA; Schimpff, SC; Wade, JC; Wiernik, PH1
Bernstein, JM; Brummett, RE; Gorse, GJ; Levin, RD; Linzmayer, MI; Lorber, RR; Markowitz, N; Pegram, PS; Saravolatz, LD1

Trials

2 trial(s) available for piperacillin and Deafness, Transitory

ArticleYear
Comparison of standard versus pharmacokinetically adjusted amikacin dosing in granulocytopenic cancer patients.
    Antimicrobial agents and chemotherapy, 1982, Volume: 22, Issue:2

    Topics: Agranulocytosis; Amikacin; Bacterial Infections; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Fever; Hearing Loss; Humans; Kanamycin; Kidney; Kinetics; Moxalactam; Neoplasms; Piperacillin; Ticarcillin

1982
Relative efficacy and toxicity of netilmicin and tobramycin in oncology patients.
    Archives of internal medicine, 1986, Volume: 146, Issue:12

    Topics: Adult; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Drug Therapy, Combination; Hearing Loss; Humans; Immune Tolerance; Infections; Middle Aged; Neoplasms; Netilmicin; Piperacillin; Prospective Studies; Random Allocation; Tobramycin

1986